These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20835856)

  • 1. The American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) algorithm for managing glycaemia in patients with type 2 diabetes mellitus: comparison with the ADA/EASD algorithm.
    Rodbard HW; Jellinger PS
    Diabetologia; 2010 Nov; 53(11):2458-60. PubMed ID: 20835856
    [No Abstract]   [Full Text] [Related]  

  • 2. Approaches to treatment 2: Comparison of American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA) type 2 diabetes treatment guidelines.
    Bloomgarden ZT; Handelsman Y
    J Diabetes; 2016 Jan; 8(1):4-6. PubMed ID: 26431291
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE.
    Cornell S
    J Am Pharm Assoc (2003); 2017; 57(2):261-265. PubMed ID: 28065547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positioning of sodium-glucose cotransporter-2 inhibitors in national and international guidelines.
    Morillas C
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():49-53. PubMed ID: 28760226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithm.
    Bailey T
    Am J Med; 2013 Sep; 126(9 Suppl 1):S10-20. PubMed ID: 23953074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing current diagnostic criteria and treatment algorithms for managing type 2 diabetes mellitus.
    Kruger DF; Boucher JL; Banerji MA
    Postgrad Med; 2011 Jul; 123(4):54-62. PubMed ID: 21680989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARY.
    Garber AJ; Abrahamson MJ; Barzilay JI; Blonde L; Bloomgarden ZT; Bush MA; Dagogo-Jack S; DeFronzo RA; Einhorn D; Fonseca VA; Garber JR; Garvey WT; Grunberger G; Handelsman Y; Hirsch IB; Jellinger PS; McGill JB; Mechanick JI; Rosenblit PD; Umpierrez GE
    Endocr Pract; 2018 Jan; 24(1):91-120. PubMed ID: 29368965
    [No Abstract]   [Full Text] [Related]  

  • 8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
    Grunberger G; Handelsman Y; Bloomgarden ZT; Fonseca VA; Garber AJ; Haas RA; Roberts VL; Umpierrez GE
    Endocr Pract; 2018 Mar; 24(3):302-308. PubMed ID: 29547046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To what extent is the new position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) 'personalised'?
    Ceriello A; Gallo M; Gentile S; Giorda CB; De Micheli A;
    Diabetologia; 2012 Oct; 55(10):2853-2855. PubMed ID: 22801904
    [No Abstract]   [Full Text] [Related]  

  • 10. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY PROTOCOL FOR STANDARDIZED PRODUCTION OF CLINICAL PRACTICE GUIDELINES, ALGORITHMS, AND CHECKLISTS - 2017 UPDATE.
    Mechanick JI; Pessah-Pollack R; Camacho P; Correa R; Figaro MK; Garber JR; Jasim S; Pantalone KM; Trence D; Upala S
    Endocr Pract; 2017 Aug; 23(8):1006-1021. PubMed ID: 28786720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critique of the 2012 ADA/EASD position statement.
    Rodbard HW; Jellinger PS
    Diabetologia; 2012 Oct; 55(10):2850-2852. PubMed ID: 22801905
    [No Abstract]   [Full Text] [Related]  

  • 12. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M; Zangeneh F; Bush MA
    Endocr Pract; 2017 Apr; 23(4):479-497. PubMed ID: 28156151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.
    Samson SL; Vellanki P; Blonde L; Christofides EA; Galindo RJ; Hirsch IB; Isaacs SD; Izuora KE; Low Wang CC; Twining CL; Umpierrez GE; Valencia WM
    Endocr Pract; 2023 May; 29(5):305-340. PubMed ID: 37150579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis.
    Schernthaner G; Barnett AH; Betteridge DJ; Carmena R; Ceriello A; Charbonnel B; Hanefeld M; Lehmann R; Malecki MT; Nesto R; Pirags V; Scheen A; Seufert J; Sjohölm A; Tsatsoulis A; DeFronzo R
    Diabetologia; 2010 Jul; 53(7):1258-69. PubMed ID: 20352408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POTENTIAL PLACE OF SGLT2 INHIBITORS IN TREATMENT PARADIGMS FOR TYPE 2 DIABETES MELLITUS.
    Handelsman Y
    Endocr Pract; 2015 Sep; 21(9):1054-65. PubMed ID: 26132997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS -
    Mechanick JI; Apovian C; Brethauer S; Garvey WT; Joffe AM; Kim J; Kushner RF; Lindquist R; Pessah-Pollack R; Seger J; Urman RD; Adams S; Cleek JB; Correa R; Figaro MK; Flanders K; Grams J; Hurley DL; Kothari S; Seger MV; Still CD
    Endocr Pract; 2019 Dec; 25(12):1346-1359. PubMed ID: 31682518
    [No Abstract]   [Full Text] [Related]  

  • 17. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
    Inzucchi SE; Bergenstal RM; Buse JB; Diamant M; Ferrannini E; Nauck M; Peters AL; Tsapas A; Wender R; Matthews DR
    Diabetologia; 2012 Jun; 55(6):1577-96. PubMed ID: 22526604
    [No Abstract]   [Full Text] [Related]  

  • 19. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.
    Garber AJ; Abrahamson MJ; Barzilay JI; Blonde L; Bloomgarden ZT; Bush MA; Dagogo-Jack S; DeFronzo RA; Einhorn D; Fonseca VA; Garber JR; Garvey WT; Grunberger G; Handelsman Y; Henry RR; Hirsch IB; Jellinger PS; McGill JB; Mechanick JI; Rosenblit PD; Umpierrez GE; ;
    Endocr Pract; 2016 Jan; 22(1):84-113. PubMed ID: 26731084
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Decision Support System for Diabetes Based on Ontology Reasoning and TOPSIS Analysis.
    Chen RC; Jiang HQ; Huang CY; Bau CT
    J Healthc Eng; 2017; 2017():4307508. PubMed ID: 29312655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.